1,720,976 research outputs found

    Discovery of a stable vitamin C glycoside in crab apples (Malus sylvestris)

    No full text
    Richardson, Alistair T., Cho, Jung, McGhie, Tony K., Larsen, David S., Schaffer, Robert J., Espley, Richard V., Perry, Nigel B. (2020): Discovery of a stable vitamin C glycoside in crab apples (Malus sylvestris). Phytochemistry (112297) 173: 1-9, DOI: 10.1016/j.phytochem.2020.112297, URL: http://dx.doi.org/10.1016/j.phytochem.2020.11229

    Fig. 4. 1H in Discovery of a stable vitamin C glycoside in crab apples (Malus sylvestris)

    No full text
    Fig. 4. 1H NMR spectra (400 MHz, D O) of a crab apple extract fraction (I) and sucrose (II). The circled signal was consistent with the anomeric proton of a β-AAG.Published as part of Richardson, Alistair T., Cho, Jung, McGhie, Tony K., Larsen, David S., Schaffer, Robert J., Espley, Richard V. & Perry, Nigel B., 2020, Discovery of a stable vitamin C glycoside in crab apples (Malus sylvestris), pp. 1-9 in Phytochemistry (112297) 173 on page 4, DOI: 10.1016/j.phytochem.2020.112297, http://zenodo.org/record/829446

    Fig. 8 in Discovery of a stable vitamin C glycoside in crab apples (Malus sylvestris)

    No full text
    Fig. 8. The downfield regions of the 1H NMR spectra for acetylated ascorbyl glycosides (structures in Fig. 7.). I. Peracetyl galactoside 9a, II. Acetylated and purified ascorbyl glycoside from crab apples, III. Peracetyl glucoside 9.Published as part of Richardson, Alistair T., Cho, Jung, McGhie, Tony K., Larsen, David S., Schaffer, Robert J., Espley, Richard V. & Perry, Nigel B., 2020, Discovery of a stable vitamin C glycoside in crab apples (Malus sylvestris), pp. 1-9 in Phytochemistry (112297) 173 on page 6, DOI: 10.1016/j.phytochem.2020.112297, http://zenodo.org/record/829446

    Fig. 1 in Discovery of a stable vitamin C glycoside in crab apples (Malus sylvestris)

    No full text
    Fig. 1. Structures of AA (1) and the only known naturally occurring derivatives in plants, 2-O-β-D-glucopyranosyl L-ascorbic acid (2) and 6-O-β-D-glucopyranosyl L-ascorbic acid (3). Synthetic 2-O-α-D-glucopyranosyl L-ascorbic acid (4) is commonly used in cosmetic products.Published as part of Richardson, Alistair T., Cho, Jung, McGhie, Tony K., Larsen, David S., Schaffer, Robert J., Espley, Richard V. & Perry, Nigel B., 2020, Discovery of a stable vitamin C glycoside in crab apples (Malus sylvestris), pp. 1-9 in Phytochemistry (112297) 173 on page 2, DOI: 10.1016/j.phytochem.2020.112297, http://zenodo.org/record/829446

    Fig. 7 in Discovery of a stable vitamin C glycoside in crab apples (Malus sylvestris)

    No full text
    Fig. 7. Acetylation of 2 under basic conditions gave the unsaturated glycoside 8, but acidic conditions led to the successful acetylation of both 2 and 2a. I. Ac2O, pyridine, 0 ̊C, overnight, 44%. II. Ac2O, HClO4, 0 ̊C, 1 h, 71% (9) and 73% (9a) yield.Published as part of Richardson, Alistair T., Cho, Jung, McGhie, Tony K., Larsen, David S., Schaffer, Robert J., Espley, Richard V. & Perry, Nigel B., 2020, Discovery of a stable vitamin C glycoside in crab apples (Malus sylvestris), pp. 1-9 in Phytochemistry (112297) 173 on page 5, DOI: 10.1016/j.phytochem.2020.112297, http://zenodo.org/record/829446

    Fig. 3 in Discovery of a stable vitamin C glycoside in crab apples (Malus sylvestris)

    No full text
    Fig. 3. LC-MS chromatograms (Instrument B, method I) of crab apple extract, commercial 2-O-α-D-glucopyranosyl L-ascorbic (4), and two AAGs produced by chemical synthesis, 2-O-β-D-glucopyranosyl L-ascorbic (2) and 2-O-β-D-galactopyranosyl L-ascorbic (2a). The traces are extracted ion chromatograms for m/z 337 [M – H]-. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)Published as part of Richardson, Alistair T., Cho, Jung, McGhie, Tony K., Larsen, David S., Schaffer, Robert J., Espley, Richard V. & Perry, Nigel B., 2020, Discovery of a stable vitamin C glycoside in crab apples (Malus sylvestris), pp. 1-9 in Phytochemistry (112297) 173 on page 3, DOI: 10.1016/j.phytochem.2020.112297, http://zenodo.org/record/829446

    Fig. 2 in Discovery of a stable vitamin C glycoside in crab apples (Malus sylvestris)

    No full text
    Fig. 2. Left: PCA (Pareto scaling with 95% confidence interval) of the LC-MS analyses of extracts from four fruit of each of nine apple accessions: green triangles = M. sylvestris, red circles = M. domestica, purple Xs = M. sieversii. Right: PCA of molecular features showing that M. domestica accessions were characterised by polyphenols (red), M. sieversii by fatty acids (blue) and M. sylvestris by dihydrochalcones (green). A molecular feature tentatively identified as an ascorbyl glycoside (top left) was also associated with two M. sylvestris accessions. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)Published as part of Richardson, Alistair T., Cho, Jung, McGhie, Tony K., Larsen, David S., Schaffer, Robert J., Espley, Richard V. & Perry, Nigel B., 2020, Discovery of a stable vitamin C glycoside in crab apples (Malus sylvestris), pp. 1-9 in Phytochemistry (112297) 173 on page 3, DOI: 10.1016/j.phytochem.2020.112297, http://zenodo.org/record/829446

    Fig. 5 in Discovery of a stable vitamin C glycoside in crab apples (Malus sylvestris)

    No full text
    Fig. 5. Synthetic route to AAGs 2 and 2a. I. Acetone, CH3COCl, overnight, room temp. (RT), II. PhCH2Br, K2CO3, DMSO, 50 ̊C, 3.5 h, III. NaOH(aq), TBAB, CHCl3, 50 ̊C, 1 h, IV. Conc. HCl, MeOH, 40 ̊C, 45 min, V. H /Pd–C, MeOH, RT, 3 h, VI. MeONa, MeOH, 20 min, RT, IRA 120 (H +), overall yield 17% (2) and 24% (2a).Published as part of Richardson, Alistair T., Cho, Jung, McGhie, Tony K., Larsen, David S., Schaffer, Robert J., Espley, Richard V. & Perry, Nigel B., 2020, Discovery of a stable vitamin C glycoside in crab apples (Malus sylvestris), pp. 1-9 in Phytochemistry (112297) 173 on page 4, DOI: 10.1016/j.phytochem.2020.112297, http://zenodo.org/record/829446

    The chemistry of the bioluminescence of the New Zealand Glow-Worm

    No full text
    The aim of the research described in this thesis was to discover the luciferin responsible for bioluminescence in the New Zealand glow-worm (GW) Arachnocampa luminosa. This work was done in partnership with Dr Miriam Sharpe whose focus was to elucidate the luciferase. In order to determine the structure of the GW luciferin, the luciferin had to be isolated from the GW and the structure elucidated via characterisation. However, luciferin purifications pose a unique isolation challenge, combining the difficulties of isolating material from source organisms, working with unstable materials, and working with enzymatic assays. Furthermore characterisation of luciferins is often difficult due to the small amounts that can be isolated and because luciferins are often highly unstable. Previous work on luciferins in other organisms and on the GW luciferin is reveiwed in Chapter 1. Chapter 1 also reviews the general literature on bioluminescence but with a focus on luciferins rather than luciferases. Chapters 2 describes the collection of Arachnocampa luminosa from the wild, and the development of a GW bioluminescence assay that enabled GW luminescent molecules to be detected. This assay enabled the detection of two different types of luminescence: P type luminescence and L type luminescence. Chapter 3 describes the separation of glow-worm lysates by reverse phase chromatography and how the luminescence assay was used to trace GW luminescent molecules through the purification process. This led to the discovery of two glow-worm luciferin precursors: tyrosine and xanthurenic acid that gave P type luminescence with the GW bioluminescence assay. The compound responsible for the L type luminescence was separated away from the compounds responsible for P type luminescence but could not be isolated. The compound responsible for L type luminescence was found to co-elute with tryptophan and is thought to be the GW luciferin. Chapter 4 describes how commercial samples of these precursors (xanthurenic acid and tyrosine), along with GW enzymes, were used to produce a compound (LRPA) that could be characterised by MS and 1H NMR. A solution of LRPA was found to produce L type luminescence with the luminescence assay showing LRPA to be either the GW luciferin or a closely related compound. Chapter 5 then describes the synthesis of two molecules (N-carbamyl tyrosine and phenol-O-carbamyl tyrosine) that were candidates for a compound that co-eluted with tyrosine. Neither of these molecules matched the unknown candidate which was later found to be 3-OH kynurenine. The research on the New Zealand glow-worm described in this thesis required intensive use of LC-MS techniques. However the research was often slowed by a shortage of glow-worms. These techniques were therefore used to investigate another New Zealand natural products problem involving insect metabolites; the origins of tutin, hyenanchin and the tutin glucosides found in New Zealand toxic honeys. Chapter 6 therefore describes a quantitative LC-MS study that shows that these compounds are of plant, not insect origin and that tutu may use glycosylation to aid in tutu transport

    The chemistry of the bioluminescence of the New Zealand Glow-Worm

    Full text link
    The aim of the research described in this thesis was to discover the luciferin responsible for bioluminescence in the New Zealand glow-worm (GW) Arachnocampa luminosa. This work was done in partnership with Dr Miriam Sharpe whose focus was to elucidate the luciferase. In order to determine the structure of the GW luciferin, the luciferin had to be isolated from the GW and the structure elucidated via characterisation. However, luciferin purifications pose a unique isolation challenge, combining the difficulties of isolating material from source organisms, working with unstable materials, and working with enzymatic assays. Furthermore characterisation of luciferins is often difficult due to the small amounts that can be isolated and because luciferins are often highly unstable. Previous work on luciferins in other organisms and on the GW luciferin is reveiwed in Chapter 1. Chapter 1 also reviews the general literature on bioluminescence but with a focus on luciferins rather than luciferases. Chapters 2 describes the collection of Arachnocampa luminosa from the wild, and the development of a GW bioluminescence assay that enabled GW luminescent molecules to be detected. This assay enabled the detection of two different types of luminescence: P type luminescence and L type luminescence. Chapter 3 describes the separation of glow-worm lysates by reverse phase chromatography and how the luminescence assay was used to trace GW luminescent molecules through the purification process. This led to the discovery of two glow-worm luciferin precursors: tyrosine and xanthurenic acid that gave P type luminescence with the GW bioluminescence assay. The compound responsible for the L type luminescence was separated away from the compounds responsible for P type luminescence but could not be isolated. The compound responsible for L type luminescence was found to co-elute with tryptophan and is thought to be the GW luciferin. Chapter 4 describes how commercial samples of these precursors (xanthurenic acid and tyrosine), along with GW enzymes, were used to produce a compound (LRPA) that could be characterised by MS and 1H NMR. A solution of LRPA was found to produce L type luminescence with the luminescence assay showing LRPA to be either the GW luciferin or a closely related compound. Chapter 5 then describes the synthesis of two molecules (N-carbamyl tyrosine and phenol-O-carbamyl tyrosine) that were candidates for a compound that co-eluted with tyrosine. Neither of these molecules matched the unknown candidate which was later found to be 3-OH kynurenine. The research on the New Zealand glow-worm described in this thesis required intensive use of LC-MS techniques. However the research was often slowed by a shortage of glow-worms. These techniques were therefore used to investigate another New Zealand natural products problem involving insect metabolites; the origins of tutin, hyenanchin and the tutin glucosides found in New Zealand toxic honeys. Chapter 6 therefore describes a quantitative LC-MS study that shows that these compounds are of plant, not insect origin and that tutu may use glycosylation to aid in tutu transport
    corecore